Recently, Prof. Bernd Plietker and his team at the Organic Chemistry I lab, TUD, came up with this group of natural substances called polyprenylated polycyclic acylphloroglucinols, or simply Ppap. The interesting part is its derivative called PPAP53. Since, it has got some serious potential in the world of medicinal chemistry. Teaming up with Ulm and Mainz Universities, their research is showing that PPAP53 could be a game-changer in tackling multi-resistant tuberculosis. And, it also might just be the key to treating neurodegenerative diseases. Tackling Tuberculosis Tuberculosis or TB hits millions…

The post PPAP53: A Game-Changer in Tuberculosis Treatment first appeared on TechieTonics.